Publicacións en colaboración con investigadores/as de Complejo Hospitalario de Toledo (20)

2023

  1. Contemporary use of cefazolin for MSSA infective endocarditis: analysis of a national prospective cohort

    International Journal of Infectious Diseases, Vol. 137, pp. 134-143

  2. Trends in cardiovascular care in the National Health System in Spain. Data from the RECALCAR project 2011-2020

    Revista Espanola de Cardiologia, Vol. 76, Núm. 7, pp. 519-530

2022

  1. Outpatient Parenteral Antibiotic Treatment vs Hospitalization for Infective Endocarditis: Validation of the OPAT-GAMES Criteria

    Open Forum Infectious Diseases, Vol. 9, Núm. 9

2021

  1. Lipid lowering treatment in patients with very high risk cardiovascular disease. Spanish Society of Cardiology Consensus Document for the use of PCSK9 inhibitors in clinical practice

    REC: CardioClinics, Vol. 56, Núm. 1, pp. 39-48

  2. Long-term prognosis of women with Brugada syndrome and electrophysiological study

    Heart Rhythm, Vol. 18, Núm. 5, pp. 664-671

2019

  1. Role of age and comorbidities in mortality of patients with infective endocarditis

    European Journal of Internal Medicine, Vol. 64, pp. 63-71

2018

  1. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis

    Journal of Infection and Chemotherapy, Vol. 24, Núm. 7, pp. 555-562

  2. Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasm

    Europace, Vol. 20, Núm. 5, pp. 851-858

2017

  1. Infective endocarditis in patients with cancer: A consequence of invasive procedures or a harbinger of neoplasm? A prospective, multicenter cohort

    Medicine (United States), Vol. 96, Núm. 38

2016

  1. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study

    Heart Rhythm, Vol. 13, Núm. 3, pp. 669-682

  2. Necesidades no cubiertas con el tratamiento hipolipemiante oral: documento de posición de la Sociedad Española de Cardiología

    Revista Espanola de Cardiologia, Vol. 69, Núm. 11, pp. 1083-1087

2015

  1. Clinical Practice Guideline (CPG). Recommendations on strategy for reducing risk of heart failure patients requiring noncardiac surgery: Reducing risk of heart failure patients in noncardiac surgery

    Revista Espanola de Anestesiologia y Reanimacion, Vol. 62, Núm. 7, pp. 359-419

  2. Left-sided infective endocarditis in patients with liver cirrhosis

    Journal of Infection, Vol. 71, Núm. 6, pp. 627-641

2014

  1. Identification of a circulating microvesicle protein network involved in ST-elevation myocardial infarction

    Thrombosis and Haemostasis, Vol. 112, Núm. 4, pp. 716-726

2013

  1. In-hospital and mid-term predictors of mortality after transcatheter aortic valve implantation: Data from the Tavi national registry 2010-2011

    Revista Espanola de Cardiologia, Vol. 66, Núm. 12, pp. 949-958

2012

  1. Precisión diagnóstica del electrocardiograma asistido por ordenador al diagnosticar hipertrofia ventricular izquierda en el bloqueo de rama izquierda

    Revista Espanola de Cardiologia, Vol. 65, Núm. 1, pp. 38-46

2011

  1. Pathological ankle-brachial index is equivalent of advanced age in acute coronary syndromes

    European Journal of Clinical Investigation, Vol. 41, Núm. 12, pp. 1268-1274

2010

  1. Usefulness of an abnormal ankle-brachial index for detecting multivessel coronary disease in patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 63, Núm. 1, pp. 54-59

2009

  1. Additive value of diabetes and peripheral arterial disease in the risk stratification of patients admitted after an acute coronary syndrome: A subanalysis of the PAMISCA Study

    International Journal of Clinical Practice, Vol. 63, Núm. 9, pp. 1314-1319

2008

  1. Prevalence and Prognostic Influence of Peripheral Arterial Disease in Patients ≥40 Years Old Admitted into Hospital Following an Acute Coronary Event

    European Journal of Vascular and Endovascular Surgery, Vol. 36, Núm. 2, pp. 189-196